EMERYVILLE, Calif.,
Nov. 30, 2021 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic
biotechnology company accelerating the world to sustainable
consumption through its Lab-to-Market™ operating
platform, today announced strong year-over-year consumer sales
performance during this year's Black Friday sales week.
Consumer sales for Black Friday week exceeded $10 million, more than doubling last year's
performance and representing the best week of Amyris consumer sales
on record. With a record 791,000 consumer visits to Amyris'
direct-to-consumer websites during the week, approximately 50% of
consumer sales came from online channels.
"All our consumer brands and channels demonstrated a very strong
performance during Black Friday sales week, setting new consumer
sales records for orders shipped and new consumers coming to our
brands," commented John Melo,
President and Chief Executive Officer of Amyris. "With advance
holiday season planning and solid execution, we have been able to
work through the supply chain challenges thus far this quarter and
meet strong demand for our consumer products. In addition to solid
sales performance from our core business, we are focused on the
successful completion of human trials in South Africa so that we can move to regulatory
approval and commercialization of our COVID-19 RNA vaccine and help
provide a solution to parts of the world that have not had access
to a COVID-19 vaccine."
About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology
company, transitioning the Clean Health & Beauty and Flavors
& Fragrances markets to sustainable ingredients through
fermentation and the company's proprietary
Lab-to-Market™ operating platform. This Amyris
platform leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products.
Forward-Looking Statements
This release contains forward-looking statements, and any
statements other than statements of historical fact could be deemed
to be forward-looking statements. These forward-looking statements
include, among other things, statements regarding 2021 fourth
quarter consumer sales revenue and the potential completion of
human trials, regulatory approval and commercialization of Amyris'
COVID-19 RNA vaccine to provide a solution to parts of the world
that have limited access to a vaccine. These statements are based
on management's current expectations and actual results and future
events may differ materially due to risks and uncertainties,
including risks related to Amyris' liquidity and ability to fund
operating and capital expenses, risks related to potential delays
or failures in development, approval, production and
commercialization of products, risks related to Amyris' reliance on
third parties (including in the supply chain), and other risks
detailed from time to time in filings Amyris makes with the
Securities and Exchange Commission, including Annual Reports on
Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K. Amyris disclaims any obligation to update information
contained in these forward-looking statements, whether as a result
of new information, future events, or otherwise.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original
content:https://www.prnewswire.com/news-releases/amyris-consumer-brands-deliver-record-black-friday-week-301433797.html
SOURCE Amyris, Inc.